Effect of inhibition of lipolysis on infarct size after experimental coronary artery occlusion
- PMID: 4718963
- PMCID: PMC302452
- DOI: 10.1172/JCI107358
Effect of inhibition of lipolysis on infarct size after experimental coronary artery occlusion
Abstract
Recent studies have demonstrated a depressant effect of increased delivery of FFA to the hypoxic heart. Because catecholamines are released in acute myocardial infarction, it is likely that lipolytic activity is increased. The purpose of this study was to determine whether inhibition of hormone-sensitive lipases influence the extent and severity of myocardial ischemic injury produced by coronary occlusion. Myocardial infarction was produced by occlusion of the left anterior descending coronary artery in open-chest dogs. 15 min later a surface map of S-T segments was obtained with the use of 10-14 epicardial leads in the distribution area of the occluded artery. Average S-T segment elevation of all sites was used as an index of myocardial ischemic injury. Before coronary occlusion, the average S-T segment elevation was 0.3+/-0.2, which increased to 4.1+/-0.7 mV (SEM, 12 dogs) after occlusion. Inhibition of lipolytic activity by beta-pyridyl-carbinol before repeated coronary occlusion reduced the occlusion-induced S-T segment elevation to 2.1+/-0.6 mV (P < 0.001). When arterial concentrations of FFA were raised by i.v. infusion of a triglyceride emulsion and heparin, average S-T segment elevation after coronary occlusion increased from 1.2+/-0.7 to 2.2+/-0.8 mV (P < 0.05) in animals treated with beta-pyridyl-carbinol, which suggests an unfavorable effect of circulating FFA in this setting. Isoproterenol given before a repeated occlusion increased the severity and extent of the ischemic injury. The effect of isoproterenol on the occlusion-induced S-T segment elevation was reduced, however, when the lipolytic effect of the drug was inhibited by beta-pyridyl-carbinol. Our study suggests that beta-pyridyl-carbinol during acute coronary artery occlusion may be of importance in reducing the extent and severity of myocardial ischemic injury.
Similar articles
-
Importance of free fatty acids as a determinant of myocardial oxygen consumption and myocardial ischemic injury during norepinephrine infusion in dogs.J Clin Invest. 1974 May;53(5):1290-9. doi: 10.1172/JCI107676. J Clin Invest. 1974. PMID: 4825226 Free PMC article.
-
Effects of hypoxemia on the extent of myocardial necrosis after experimental coronary occlusion.Am J Cardiol. 1975 Jun;35(6):795-800. doi: 10.1016/0002-9149(75)90114-9. Am J Cardiol. 1975. PMID: 1130288
-
Effects of p-chlorophenoxyisobutyrate on myocardial free fatty acid extraction, ventricular blood flow, and epicardial ST-segment elevation during coronary occlusion in dogs.Circulation. 1976 Mar;53(3):494-500. doi: 10.1161/01.cir.53.3.494. Circulation. 1976. PMID: 1248082
-
Reduction of experimental myocardial infarct size by corticosteroid administration.J Clin Invest. 1973 Mar;52(3):599-607. doi: 10.1172/JCI107221. J Clin Invest. 1973. PMID: 4685084 Free PMC article.
-
Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion.J Clin Invest. 1978 Mar;61(3):661-70. doi: 10.1172/JCI108978. J Clin Invest. 1978. PMID: 641147 Free PMC article.
Cited by
-
Metabolic intervention in acute ischaemia.Proc R Soc Med. 1976 Mar;69(3):207-11. doi: 10.1177/003591577606900315. Proc R Soc Med. 1976. PMID: 1265015 Free PMC article. No abstract available.
-
Importance of free fatty acids as a determinant of myocardial oxygen consumption and myocardial ischemic injury during norepinephrine infusion in dogs.J Clin Invest. 1974 May;53(5):1290-9. doi: 10.1172/JCI107676. J Clin Invest. 1974. PMID: 4825226 Free PMC article.
-
Animal models of myocardial ischaemia.J Clin Pathol Suppl (R Coll Pathol). 1977;11:53-8. doi: 10.1136/jcp.s3-11.1.53. J Clin Pathol Suppl (R Coll Pathol). 1977. PMID: 269120 Free PMC article. No abstract available.
-
Effects of cardioselective and non-cardioselective beta-blockade on adrenaline-induced metabolic and cardiovascular responses in man.Eur J Clin Pharmacol. 1981;20(1):17-22. doi: 10.1007/BF00554661. Eur J Clin Pharmacol. 1981. PMID: 6118277
-
Protection against experimental myocardial ischaemia by L-4-hydroxy-phenylglycine, a new agent which alters myocardial metabolic balance in favour of carbohydrate utilisation [proceedings].Br J Pharmacol. 1979 Jul;66(3):443P-444P. Br J Pharmacol. 1979. PMID: 526733 Free PMC article. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources